The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Therapeutic goods regulation (38)
- Manufacturing (26)
- Regulatory compliance (26)
- Unique Device Identification (UDI) hub (20)
- In Vitro Diagnostic medical devices (IVDs) (18)
- Prescription medicines (17)
- Safety (10)
- Medical devices safety (9)
- Australian Register of Therapeutic Goods (ARTG) (8)
- Clinical trials (8)
- Legislation (8)
- Medicine safety (8)
- Vaping hub (8)
- Scheduling (national classification system) (7)
- Medicinal cannabis hub (5)
- Over the counter (OTC) medicines (5)
- Advertising (4)
- Listed medicines (3)
- Non-prescription medicines (3)
- Shortages (3)
- Breast implant hub (2)
- Complementary medicines (2)
- Compliance and enforcement hub (2)
- Pharmacovigilance (2)
- Advanced therapies (1)
- Advisory bodies and committees (1)
- Alert/Advisory (1)
- Blood and blood components (1)
- Cosmetics (1)
- COVID-19 vaccines (1)
- Import and export (1)
- Labelling and packaging (1)
- TGA conformity assessment certification (1)
Search
198 result(s) found, displaying 1 to 25
-
WebinarsThis is a Q&A Session for Industry about the recently published guidance on listed probiotic medicines.
-
PresentationsAn overview of the amended sponsor portal to include unapproved medical devices and provides guidance on how to apply for consent to import, supply or export medical devices that do not comply with the Essential Principles (EPs).
-
WebinarsGuidance on completing updated notification form for new therapeutic vaping products, and information on the re-statement of compliance when requested by TGA.
-
PresentationsSee the upcoming changes in the PRAC – the new procedure document that will replace the Uniform Recalls Procedure for Therapeutic Goods (URPTG).
-
PresentationsPresentations given by the TGA at the ARCS 2025 Regulatory Summit, 19 February 2025
-
PresentationsPresentation given at the 2024 ACTA Symposium, in Melbourne
-
PresentationsPresentations given by the TGA at the GMP Forum 19-20 November, Melbourne Convention and Exhibition Centre.
-
PresentationsChanges to applicable product standards for unapproved therapeutic vaping goods in 2025
-
PresentationsHear about the options we currently considering in relation to the future regulation of assistive technologies. Q and A session included.
-
WebinarsView the proposed changes to the post-market review compliance portal allowing sponsors of exempt devices to view and respond to regulatory notices, and ask questions and provide feedback on the proposed changes.
-
WebinarsWebinar giving an overview of the software reclassification reforms and the transitional arrangements for software based medical devices affected by the changes.
-
WebinarsView the proposed changes to the on-line application form for consent to import, export, or supply medical devices that do not comply with the Essential Principles.
-
PresentationsThis webinar provides information about the TGA’s public consultation paper on the proposed changes to the Australian Essential Principles and an opportunity to ask questions.
-
PresentationsAbout the changes to the compounding of glucagon-like peptide-1 receptor agonist (GLP-1 RA) products and how these changes will impact pharmacists, doctors and consumers.
-
PresentationsWebinar Tuesday 20 and Wednesday 21 August 2024
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
-
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
-
PresentationsPresentations given by the TGA at the 2024 ARCS Annual Conference, 12-14 June 2024.